Atlas Trials

Evaluation of Immunogenicity of COVID-19 Vaccine in Chinese Population

Clinical trial NCT06763887 · COMPLETED

Trial details

NCT number
NCT06763887
Sponsor
Xijing Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
COVID
Start date
2023-11-15
Primary completion
2024-06-30
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.